SMARCB1 and embryonal neoplasm: According to the World Health Organization (WHO) 2016 and 2021 classification, diagnosis of ATRTs requires INI1 confirmation and tumors without INI1 loss should be reported as CNS embryonal tumors with rhabdoid features.